Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
Condition(s):Brain and Central Nervous System TumorsLast Updated:March 6, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Brain and Central Nervous System TumorsLast Updated:March 6, 2019Completed
Condition(s):Epilepsy; Mental RetardationLast Updated:March 19, 2009Unknown status
Condition(s):Schizophrenia; Bipolar EpisodesLast Updated:December 15, 2015Completed
Condition(s):Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety DisordersLast Updated:February 28, 2018Terminated
Condition(s):Bipolar DisorderLast Updated:September 15, 2005Completed
Condition(s):Bipolar DisorderLast Updated:May 4, 2007Completed
Condition(s):EpilepsyLast Updated:May 4, 2017Unknown status
Condition(s):EpilepsyLast Updated:March 27, 2020Completed
Condition(s):EpilepsyLast Updated:August 29, 2017Terminated
Condition(s):Healthy; Mood DisordersLast Updated:March 4, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.